Europe Canada Oncology Market Access & Pricing Director

Are you ready to shape regional access and pricing strategies that get transformative cancer medicines to patients faster across Europe and Canada(EUCAN)?

In this role, you will steer regional strategy and execution for priority oncology portfolios, aligning evidence, value, and pricing to deliver impact at launch and throughout the lifecycle.

Based in Baar, Switzerland and reporting to the Head of EUCAN Oncology Market Access & Pricing, you willoperateat the intersection of science, policy, and commercial execution. You will partner closely with global, regional, and country teams to navigate EU HTA implementation, evolving evidence requirements, international reference pricing, and shifting oncology funding models,turning complexity into clear, actionable strategies that maximize access and portfolio value.

Can youtranslatescientific innovation and evolving healthcare trends into regional access strategies that maximize patient impact and portfolio value?

Accountabilities

• Regional Strategy &ExecutionTranslateglobaloncologymarketaccess &pricing strategies into regional implementation plans across assigned franchises, bridging global intent with local market realities to delivertimelyaccess outcomes.

• Launch & PricingExcellenceLead regionalaccessreadinessand pricing excellence,optimisinglist and net price strategies, access conditions, and valuerealisationto enable best-in-class oncology launches across EUCAN.

• Lifecycle Value & Pricing InnovationDevelop pricing, reimbursement, and value strategies across the product lifecycle, includingindicationsequencing, combination pricing, and evidence-based differentiation in competitive therapeutic areas.

• Cross-Functional PartnershipCollaborate with GlobalOncologyMarketAccessPricing (OMAP), Medical, HEOR, Policy, Government Affairs, and Commercial teams to ensure evidence generation plans and value propositions meet payer and HTA requirements at regional and country level.

• External Environment & Policy ShapingMonitor and assess the implications of EU HTA, international reference pricing dynamicsincl. MFN, and evolving oncology funding models; translate insights into pragmatic regional guidance.

• Country EnablementBuild strategic partnerships with country market access leaders to driveexcellence execution, share best practice, and strengthen local capabilities.

• Business Planning IntegrationEmbed market access and pricing assumptions into business planning and forecasting cycles to inform investment decisions and portfolioprioritization

• Governance &RepresentationRepresentEUCAN market access perspectives in regional and global governance forums, ensuring priorities, risks, and opportunities are visible and addressed.

Essential Skills & Experience

• Qualification:Master’s degree in health economics, Economics, Life Sciences, or a closely related discipline.

• Market Access Expertise: 10+ years' experience in Market Access, Pricing, or HEOR within the pharmaceutical industry,withsignificantoncology experience

• European Payer Knowledge:Demonstrated, hands-on understanding of European HTA and reimbursement systems including familiarity with the EU HTAregulation and its implementation timeline.

• Pricing & Reimbursement Strategy: Proventrack recordof developing and executing successful pricing and access strategies across multiple European markets,

• Launch Experience: Direct involvement in at least two major oncology product launches in a regional or multi-country capacity.

• Stakeholder Influence:Demonstratedability to influence senior leaders and drive alignment in highly matrixed, globalorganisationswithout direct line authority.

• Strategic Acumen: Ability tosynthesisecomplex policy,competitive, and market dynamics into clear, commercially sound recommendations for senior leadership.

• Communication: Excellent written and verbal communication skillsinEnglish, including executive-level presentation and storytelling capability.

Desirable Skills & Experience

• Direct experience negotiating pricing and reimbursement with European payers or HTA bodies, includinginnovative access agreements,value-basedarrangementsormanaged entryagreements.

• Experience influencing evidence generation, value demonstration, or HEOR strategies to support payer and HTA decision-making.

• Experience working across Global, Regional, and Affiliate organizations in highly matrixed environments.

• Fluency in one or moreadditionalEuropean languages

When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challengeperceptionsThat'swhy we work, on average, a minimum of three days per week from the office. But thatdoesn'tmeanwe'renot flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.